초록 ▼

The present invention provides compounds that function as hydrolytic enzyme inhibitors (inactivators) and substrates. These compounds are useful in assays to detect and measure levels of hydrolytic enzyme activity and are more particularly useful in treatment regimens for various disease states and

The present invention provides compounds that function as hydrolytic enzyme inhibitors (inactivators) and substrates. These compounds are useful in assays to detect and measure levels of hydrolytic enzyme activity and are more particularly useful in treatment regimens for various disease states and conditions implicating the underlying specific hydrolytic enzyme. Examples of hydrolytic enzymes include, but are not limited to, phospholipases, lipases, esterases, proteases, etc.

대표청구항 ▼

A method for preparing a therapeutically useful composition which comprises compounding a pharmaceutically acceptable form of a compound of the formula: [Figure] with a pharmaceutically acceptable carrier, wherein R is oxygen or imino, each X independently is oxygen, sulfur or imino, A is a moiety r

A method for preparing a therapeutically useful composition which comprises compounding a pharmaceutically acceptable form of a compound of the formula: [Figure] with a pharmaceutically acceptable carrier, wherein R is oxygen or imino, each X independently is oxygen, sulfur or imino, A is a moiety recognized by phospholipase A2 enzyme wherein said enzyme hydrolyses the bond linking AX with C(O)Y, B is a physiologically acceptable leaving group, Y is an alkylene or alkenylene optionally substituted with one or more lower alkyl groups.